Showing results (2141-2150 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 29, 2005
Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategyLuciene Lopes, Kate Fletcher, Yasuhiro Ikeda, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2005
An intracellular antibody can suppress tumorigenicity in hepatitis B virus X-expressing cellsYoung-Hee Jin, Myung-Hee Kwon, Kyongmin Kim, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2005
Functional endogenous cytotoxic T lymphocytes are generated to multiple antigens co-expressed by progressing tumors; after intra-tumoral IL-2 therapy these effector cells eradicate established tumorsChristine S Bundell, Connie Jackaman, Andreas Suhrbier, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2010
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphataseBrian M Olson, Thomas P Frye, Laura E Johnson, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2010
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicityHong Lin, Elisa de Stanchina, Xi Kathy Zhou, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2009
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis modelNasreen Vohra, Monique Verhaegen, Lisa Martin, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 2009
Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K(b)-restricted T cell epitopeJung-Sun Park, Hye-Sung Kim, Mi-Young Park, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2017
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonistsTanja Lövgren, Dhifaf Sarhan, Iva Truxová, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2017
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functionsFeng Xu, Alexander Sunderland, Yue Zhou, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cellsJ K Steele, D Liu, A T Stammers, et al.
Pageof 652